EP Biocomposites FY26: Revenue up 13.6%, EBITDA 26%, PAT 41.5%

EP Biocomposites Limited announced strong audited financial results for the financial year ended March 31, 2026. For FY26, Revenue from Operations grew 13.60% YoY to ₹1,363.98 Lakh. EBITDA increased by 26.23% YoY to ₹237.83 Lakh, with margins at 17.44%. Profit After Tax (PAT) surged by 41.4% YoY to ₹145.83 Lakh, achieving PAT margins of 10.69%. Basic EPS stood at ₹8.67. Key highlights include net worth crossing ₹12 crore, ROI at 14%, and ROCE improving to 16%. The company successfully utilized IPO proceeds for capacity expansion, working capital, and business growth, while also strengthening its balance sheet through partial debt repayment. Management expressed optimism for future growth, emphasizing sustainable manufacturing and operational excellence.